Projects funded by the NCN

Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t...

Call: SONATA BIS 14 , Panel: NZ3

Principal investigator: dr Jan Marian Suski

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t...

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr hab. Danuta Dudzik

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

Call: OPUS 25 , Panel: NZ6

Principal investigator: dr hab. Angelika Muchowicz

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

Call: OPUS 19 , Panel: NZ7

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Investigation on PD-L1 biology for precise shaping of anticancer adoptive therapies

Call: SONATA 15 , Panel: NZ6

Principal investigator: dr Agnieszka Graczyk-Jarzynka

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

New biocatalytic systems: carbon nanomaterial - enzyme, with controlled activity and potential application in anticancer...

Call: PRELUDIUM 14 , Panel: ST5

Principal investigator: Paulina Erwardt

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Mathematical modelling of drug resistance in anticancer therapies.

Call: PRELUDIUM 12 , Panel: ST1

Principal investigator: dr Mariusz Piotr Bodzioch

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Matematyki i Informatyki

System engineering approach to modeling, analysis and prediction of outcome of combined anticancer therapies

Call: OPUS 11 , Panel: ST7

Principal investigator: prof. Andrzej Świerniak

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

Nanotheranostics dedicated to targeted anticancer therapies: Novel magnetic hybrid carbon-based materials - synthesis an...

Call: PRELUDIUM 11 , Panel: ST5

Principal investigator: Artur Kasprzak

Politechnika Warszawska, Wydział Chemiczny